Clinician's Commentary on Choi et al.1. - Wikidata - awgldk - TriplyDB

Clinician's Commentary on Choi et al.1.

Clinician's Commentary on Choi et al.1.

http://www.wikidata.org/entity/Q47100319

about

Clinician's Commentary on Choi et al.1.

http://www.wikidata.org/entity/Q47100319

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Clinician's Commentary on Choi et al.1.

@en

Clinician's Commentary on Choi et al.1.

@nl

type

label

Clinician's Commentary on Choi et al.1.

@en

Clinician's Commentary on Choi et al.1.

@nl

prefLabel

Clinician's Commentary on Choi et al.1.

@en

Clinician's Commentary on Choi et al.1.

@nl

P1433

Q47100319-E44100C4-94EE-4011-B817-EC45CCDF7868

P1476

Q47100319-871C0D2D-BB34-4D44-AB56-885DE282CD39

P2093

Q47100319-A2408DAD-28B0-4B89-812B-C738026E30F4

P2860

Q47100319-11D27973-0528-4971-AA57-D4ADA6E36B68

Q47100319-3C7A1B4D-6429-416B-99A9-11A5A31A137D

Q47100319-47E1532E-D2C6-4052-8FE3-3B88DE68340C

Q47100319-7FCD31D2-5441-43BC-B5B0-3FCECF9A5540

Q47100319-83A998D6-22A7-4FA2-9076-16CACE4A5C18

Q47100319-A6ABFE38-06CD-4557-A49F-9447EA5847B8

Q47100319-B8625272-06B1-4A3F-BF8B-BABD84FFE7F6

P304

Q47100319-F84465B5-9B7F-4D2F-A211-70D46ADD400C

P31

Q47100319-A08D97CB-78B1-45D9-8282-2D7A5794509A

P356

Q47100319-40BA8E41-A8AC-4C11-8E98-B236AE64B949

P433

Q47100319-F84D68AB-F5E0-455F-AAEA-C6A3FD06698F

P478

Q47100319-5D118875-4AE8-48F3-A6AB-70A7E9688CFC

P577

Q47100319-503EB49A-B0E3-4A6E-A220-EBF9083F9B6C

P698

Q47100319-C7CB542D-F882-4E2B-92F8-70BD2AB53B91

P932

Q47100319-E793FF56-702D-4BE2-B48E-43008AC62B4B

P356

P1433

Physiotherapy Canada

P1476

Clinician's Commentary on Choi et al.1.

@en

P2093

Parvin Eftekhar

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: a systematic review of the literature.

Effect of baseline spastic hemiparesis on recovery of upper-limb function following botulinum toxin type A injections and postinjection therapy

Spasticity: clinical perceptions, neurological realities and meaningful measurement.

Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?

Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.

Goal attainment for spasticity management using botulinum toxin.

Goal Attainment Scaling in Individuals with Upper Limb Spasticity Post Stroke.

P304

120-121

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3138/PTC.2016-25-CC

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28548139

http://www.w3.org/2001/XMLSchema#string

P932

5435399

http://www.w3.org/2001/XMLSchema#string